Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)

NCT04646356 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hereditary Hemorrhagic Telangiectasia
Epistaxis Nosebleed

Interventions

DRUG: Tacrolimus capsule (low-dose)

Sponsor

Unity Health Toronto

Collaborators

[object Object]